Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression.

Porcine pancreatic islets were microencapsulated in alginate-polylysine-alginate capsules and transplanted intraperitoneally into nine spontaneously diabetic monkeys. After one, two, or three transplants of 3-7 x 10(4) islets per recipient, seven of the monkeys became insulin independent for periods ranging from 120 to 804 d with fasting blood glucose levels in the normoglycemic range. Glucose clearance rates in the transplant recipients were significantly higher than before the graft administration and the insulin secretion during glucose tolerance tests was significantly higher compared with pretransplant tests. Porcine C-peptide was detected in all transplant recipients throughout their period of normoglycemia while none was found before the graft administration. Hemoglobin A1C levels dropped significantly within 2 mo after transplantation. While ketones were detected in the urine of all recipients before the graft administration, all experimental animals became ketone free 2 wk after transplantation. Capsules recovered from two recipients 3 mo after the restoration of normoglycemia were found physically intact with enclosed islets clearly visible. The capsules were free of cellular overgrowth. Examination of internal organs of two of the animals involved in our transplantation studies for the duration of 2 yr revealed no untoward effect of the extended presence of the microcapsules.

[1]  A. Sun,et al.  The alginate‐poly‐L‐lysine‐alginate membrane: Evidence of a protective effect on microencapsulated islets of Langerhans following exposure to cytokines , 1995 .

[2]  A. Sun,et al.  Generation of alginate-poly-l-lysine-alginate (APA) biomicrocapsules: the relationship between the membrane strength and the reaction conditions. , 1994, Artificial cells, blood substitutes, and immobilization biotechnology.

[3]  A. Sun,et al.  Porcine pancreatic islets: isolation, microencapsulation, and xenotransplantation. , 2008, Artificial organs.

[4]  G. Skjåk‐Braek,et al.  SUCCESSFUL REVERSAL OF SPONTANEOUS DIABETES IN DOGS BY INTRAPERITONEAL MICROENCAPSULATED ISLETS , 1992, Transplantation.

[5]  K Hannig,et al.  Production of mitogen‐contamination free alginates with variable ratios of mannuronic acid to guluronic acid by free flow electrophoresis , 1992, Electrophoresis.

[6]  A. Sun,et al.  Prolonged Reversal of Diabetic State in NOD Mice by Xenografts of Microencapsulated Rat Islets , 1991, Diabetes.

[7]  A. Sun,et al.  Xenotransplantation of microencapsulated fetal rat islets. , 1991, Transplantation.

[8]  H. Clayton,et al.  The effect of capsule composition on the biocompatibility of alginate-poly-l-lysine capsules. , 1991, Journal of microencapsulation.

[9]  T. Starzl,et al.  Pancreatic islet transplantation after upper abdominal exeriteration and liver replacement , 1990, The Lancet.

[10]  A. Sun,et al.  Reversal of Diabetes in BB Rats by Transplantation of Encapsulated Pancreatic Islets , 1990, Diabetes.

[11]  V. D’Agati,et al.  The role of CD4+ helper T cells in the destruction of microencapsulated islet xenografts in nod mice. , 1990, Transplantation.

[12]  E. Ryan,et al.  CONTINUED FUNCTION OF PANCREATIC ISLETS AFTER TRANSPLANTATION IN TYPE I DIABETES , 1989, The Lancet.

[13]  J. Flier,et al.  Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. , 1987, The New England journal of medicine.

[14]  A. Sun,et al.  Encapsulation of Rat Islets of Langerhans Prolongs Xenograft Survival in Diabetic Mice , 1986, Diabetes.

[15]  F. Lim,et al.  Microencapsulated islets as bioartificial endocrine pancreas. , 1980, Science.